 Megan Svensen |
Megan Svensen, who did a seven-year stint as managing director at W2O Group, has joined Lippe Taylor as executive VP-healthcare as the New York firm expands its biopharmaceutical and medical device businesses.
Svensen also did eight-year runs as healthcare executive VP at Marina Maher Communications and Ogilvy.
She has worked for clients involved in women’s health, diabetes, respiratory, cardiovascular, dermatology and oncology areas.
Maureen Lippe, called Svenson “the perfect leader to support our unique blend of science and consumer know-how."
At LT, Svensen will work closely with healthcare practice leader Jennifer O’Neill, a veteran of InVentiv Health, Chamberlain Healthcare PR and Ruder Finn.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
